nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—PDE11A—epithelium—colon cancer	0.044	0.19	CbGeAlD
Tadalafil—PDE5A—endothelium—colon cancer	0.0373	0.161	CbGeAlD
Tadalafil—PDE5A—blood vessel—colon cancer	0.0344	0.148	CbGeAlD
Tadalafil—PDE11A—liver—colon cancer	0.025	0.107	CbGeAlD
Tadalafil—PDE5A—epithelium—colon cancer	0.0168	0.0721	CbGeAlD
Tadalafil—PDE5A—smooth muscle tissue—colon cancer	0.0161	0.0695	CbGeAlD
Tadalafil—PDE5A—renal system—colon cancer	0.0155	0.0669	CbGeAlD
Tadalafil—PDE5A—digestive system—colon cancer	0.0127	0.0549	CbGeAlD
Tadalafil—PDE5A—vagina—colon cancer	0.0113	0.0485	CbGeAlD
Tadalafil—PDE5A—lymph node—colon cancer	0.00728	0.0314	CbGeAlD
Tadalafil—CYP3A4—renal system—colon cancer	0.00484	0.0209	CbGeAlD
Tadalafil—CYP3A4—digestive system—colon cancer	0.00397	0.0171	CbGeAlD
Tadalafil—CYP3A4—liver—colon cancer	0.00296	0.0127	CbGeAlD
Tadalafil—Migraine—Capecitabine—colon cancer	0.00271	0.00354	CcSEcCtD
Tadalafil—Pharyngitis—Fluorouracil—colon cancer	0.00271	0.00353	CcSEcCtD
Tadalafil—Face oedema—Capecitabine—colon cancer	0.00266	0.00347	CcSEcCtD
Tadalafil—Angiopathy—Vincristine—colon cancer	0.00266	0.00346	CcSEcCtD
Tadalafil—Cardiac disorder—Irinotecan—colon cancer	0.00265	0.00345	CcSEcCtD
Tadalafil—Flushing—Irinotecan—colon cancer	0.00265	0.00345	CcSEcCtD
Tadalafil—Mediastinal disorder—Vincristine—colon cancer	0.00264	0.00344	CcSEcCtD
Tadalafil—Angiopathy—Irinotecan—colon cancer	0.00259	0.00337	CcSEcCtD
Tadalafil—Immune system disorder—Irinotecan—colon cancer	0.00257	0.00335	CcSEcCtD
Tadalafil—Mediastinal disorder—Irinotecan—colon cancer	0.00257	0.00335	CcSEcCtD
Tadalafil—Mental disorder—Vincristine—colon cancer	0.00256	0.00334	CcSEcCtD
Tadalafil—Liver function test abnormal—Capecitabine—colon cancer	0.00255	0.00332	CcSEcCtD
Tadalafil—Orthostatic hypotension—Capecitabine—colon cancer	0.00252	0.00328	CcSEcCtD
Tadalafil—Abdominal pain upper—Capecitabine—colon cancer	0.00252	0.00328	CcSEcCtD
Tadalafil—Breast disorder—Capecitabine—colon cancer	0.00249	0.00325	CcSEcCtD
Tadalafil—Nasopharyngitis—Capecitabine—colon cancer	0.00247	0.00321	CcSEcCtD
Tadalafil—Back pain—Vincristine—colon cancer	0.00246	0.00321	CcSEcCtD
Tadalafil—Gastritis—Capecitabine—colon cancer	0.00244	0.00318	CcSEcCtD
Tadalafil—Back pain—Irinotecan—colon cancer	0.0024	0.00313	CcSEcCtD
Tadalafil—Muscle spasms—Irinotecan—colon cancer	0.00239	0.00311	CcSEcCtD
Tadalafil—Influenza—Capecitabine—colon cancer	0.00238	0.0031	CcSEcCtD
Tadalafil—Dysphagia—Capecitabine—colon cancer	0.00238	0.0031	CcSEcCtD
Tadalafil—Angina pectoris—Capecitabine—colon cancer	0.00232	0.00302	CcSEcCtD
Tadalafil—Bronchitis—Capecitabine—colon cancer	0.00229	0.00299	CcSEcCtD
Tadalafil—Vertigo—Vincristine—colon cancer	0.00229	0.00298	CcSEcCtD
Tadalafil—Abdominal discomfort—Capecitabine—colon cancer	0.00228	0.00298	CcSEcCtD
Tadalafil—Vision blurred—Fluorouracil—colon cancer	0.00224	0.00292	CcSEcCtD
Tadalafil—Vertigo—Irinotecan—colon cancer	0.00223	0.0029	CcSEcCtD
Tadalafil—Syncope—Irinotecan—colon cancer	0.00223	0.0029	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Capecitabine—colon cancer	0.00222	0.00289	CcSEcCtD
Tadalafil—Convulsion—Vincristine—colon cancer	0.00221	0.00288	CcSEcCtD
Tadalafil—Hypertension—Vincristine—colon cancer	0.0022	0.00286	CcSEcCtD
Tadalafil—Loss of consciousness—Irinotecan—colon cancer	0.00218	0.00284	CcSEcCtD
Tadalafil—Dermatitis exfoliative—Methotrexate—colon cancer	0.00218	0.00283	CcSEcCtD
Tadalafil—Myalgia—Vincristine—colon cancer	0.00217	0.00283	CcSEcCtD
Tadalafil—Cough—Irinotecan—colon cancer	0.00217	0.00282	CcSEcCtD
Tadalafil—Hypertension—Irinotecan—colon cancer	0.00214	0.00279	CcSEcCtD
Tadalafil—Infestation NOS—Capecitabine—colon cancer	0.00213	0.00277	CcSEcCtD
Tadalafil—Infestation—Capecitabine—colon cancer	0.00213	0.00277	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00211	0.00274	CcSEcCtD
Tadalafil—Acute coronary syndrome—Capecitabine—colon cancer	0.00209	0.00273	CcSEcCtD
Tadalafil—Cerebrovascular accident—Methotrexate—colon cancer	0.00209	0.00273	CcSEcCtD
Tadalafil—Renal failure—Capecitabine—colon cancer	0.00209	0.00272	CcSEcCtD
Tadalafil—Discomfort—Irinotecan—colon cancer	0.00209	0.00272	CcSEcCtD
Tadalafil—Myocardial infarction—Capecitabine—colon cancer	0.00208	0.00271	CcSEcCtD
Tadalafil—Oedema—Vincristine—colon cancer	0.00208	0.00271	CcSEcCtD
Tadalafil—Infection—Vincristine—colon cancer	0.00207	0.00269	CcSEcCtD
Tadalafil—Conjunctivitis—Capecitabine—colon cancer	0.00207	0.00269	CcSEcCtD
Tadalafil—Urinary tract infection—Capecitabine—colon cancer	0.00207	0.00269	CcSEcCtD
Tadalafil—Convulsion—Fluorouracil—colon cancer	0.00206	0.00268	CcSEcCtD
Tadalafil—Nervous system disorder—Vincristine—colon cancer	0.00204	0.00266	CcSEcCtD
Tadalafil—Haematuria—Capecitabine—colon cancer	0.00203	0.00264	CcSEcCtD
Tadalafil—Oedema—Irinotecan—colon cancer	0.00203	0.00264	CcSEcCtD
Tadalafil—Chest pain—Fluorouracil—colon cancer	0.00202	0.00264	CcSEcCtD
Tadalafil—Myalgia—Fluorouracil—colon cancer	0.00202	0.00264	CcSEcCtD
Tadalafil—Infection—Irinotecan—colon cancer	0.00201	0.00262	CcSEcCtD
Tadalafil—Hyperhidrosis—Vincristine—colon cancer	0.00201	0.00262	CcSEcCtD
Tadalafil—Epistaxis—Capecitabine—colon cancer	0.002	0.00261	CcSEcCtD
Tadalafil—Discomfort—Fluorouracil—colon cancer	0.002	0.0026	CcSEcCtD
Tadalafil—Shock—Irinotecan—colon cancer	0.00199	0.00259	CcSEcCtD
Tadalafil—Nervous system disorder—Irinotecan—colon cancer	0.00199	0.00259	CcSEcCtD
Tadalafil—Hyperhidrosis—Irinotecan—colon cancer	0.00196	0.00255	CcSEcCtD
Tadalafil—Hypotension—Vincristine—colon cancer	0.00194	0.00253	CcSEcCtD
Tadalafil—Oedema—Fluorouracil—colon cancer	0.00194	0.00253	CcSEcCtD
Tadalafil—Infection—Fluorouracil—colon cancer	0.00193	0.00251	CcSEcCtD
Tadalafil—Haemoglobin—Capecitabine—colon cancer	0.00192	0.0025	CcSEcCtD
Tadalafil—Rhinitis—Capecitabine—colon cancer	0.00191	0.00249	CcSEcCtD
Tadalafil—Haemorrhage—Capecitabine—colon cancer	0.00191	0.00248	CcSEcCtD
Tadalafil—Nervous system disorder—Fluorouracil—colon cancer	0.0019	0.00248	CcSEcCtD
Tadalafil—Hypoaesthesia—Capecitabine—colon cancer	0.0019	0.00247	CcSEcCtD
Tadalafil—Liver function test abnormal—Methotrexate—colon cancer	0.0019	0.00247	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Vincristine—colon cancer	0.00189	0.00247	CcSEcCtD
Tadalafil—Pharyngitis—Capecitabine—colon cancer	0.00189	0.00247	CcSEcCtD
Tadalafil—Tachycardia—Fluorouracil—colon cancer	0.00189	0.00247	CcSEcCtD
Tadalafil—Hypotension—Irinotecan—colon cancer	0.00189	0.00246	CcSEcCtD
Tadalafil—Urinary tract disorder—Capecitabine—colon cancer	0.00188	0.00245	CcSEcCtD
Tadalafil—Insomnia—Vincristine—colon cancer	0.00188	0.00245	CcSEcCtD
Tadalafil—Oedema peripheral—Capecitabine—colon cancer	0.00188	0.00245	CcSEcCtD
Tadalafil—Connective tissue disorder—Capecitabine—colon cancer	0.00187	0.00244	CcSEcCtD
Tadalafil—Urethral disorder—Capecitabine—colon cancer	0.00187	0.00244	CcSEcCtD
Tadalafil—Paraesthesia—Vincristine—colon cancer	0.00187	0.00243	CcSEcCtD
Tadalafil—Breast disorder—Methotrexate—colon cancer	0.00186	0.00242	CcSEcCtD
Tadalafil—Insomnia—Irinotecan—colon cancer	0.00183	0.00239	CcSEcCtD
Tadalafil—Paraesthesia—Irinotecan—colon cancer	0.00182	0.00237	CcSEcCtD
Tadalafil—Hypotension—Fluorouracil—colon cancer	0.00181	0.00236	CcSEcCtD
Tadalafil—Dyspnoea—Irinotecan—colon cancer	0.00181	0.00235	CcSEcCtD
Tadalafil—Erythema multiforme—Capecitabine—colon cancer	0.0018	0.00235	CcSEcCtD
Tadalafil—Somnolence—Irinotecan—colon cancer	0.0018	0.00234	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Vincristine—colon cancer	0.0018	0.00234	CcSEcCtD
Tadalafil—Fatigue—Vincristine—colon cancer	0.00179	0.00233	CcSEcCtD
Tadalafil—Eye disorder—Capecitabine—colon cancer	0.00178	0.00232	CcSEcCtD
Tadalafil—Dyspepsia—Irinotecan—colon cancer	0.00178	0.00232	CcSEcCtD
Tadalafil—Tinnitus—Capecitabine—colon cancer	0.00178	0.00232	CcSEcCtD
Tadalafil—Pain—Vincristine—colon cancer	0.00178	0.00232	CcSEcCtD
Tadalafil—Constipation—Vincristine—colon cancer	0.00178	0.00232	CcSEcCtD
Tadalafil—Flushing—Capecitabine—colon cancer	0.00177	0.00231	CcSEcCtD
Tadalafil—Cardiac disorder—Capecitabine—colon cancer	0.00177	0.00231	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00177	0.0023	CcSEcCtD
Tadalafil—Insomnia—Fluorouracil—colon cancer	0.00175	0.00228	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Irinotecan—colon cancer	0.00175	0.00228	CcSEcCtD
Tadalafil—Fatigue—Irinotecan—colon cancer	0.00175	0.00227	CcSEcCtD
Tadalafil—Paraesthesia—Fluorouracil—colon cancer	0.00174	0.00227	CcSEcCtD
Tadalafil—Pain—Irinotecan—colon cancer	0.00173	0.00226	CcSEcCtD
Tadalafil—Constipation—Irinotecan—colon cancer	0.00173	0.00226	CcSEcCtD
Tadalafil—Angiopathy—Capecitabine—colon cancer	0.00173	0.00225	CcSEcCtD
Tadalafil—Dyspnoea—Fluorouracil—colon cancer	0.00173	0.00225	CcSEcCtD
Tadalafil—Somnolence—Fluorouracil—colon cancer	0.00172	0.00225	CcSEcCtD
Tadalafil—Immune system disorder—Capecitabine—colon cancer	0.00172	0.00224	CcSEcCtD
Tadalafil—Mediastinal disorder—Capecitabine—colon cancer	0.00172	0.00224	CcSEcCtD
Tadalafil—Dyspepsia—Fluorouracil—colon cancer	0.00171	0.00222	CcSEcCtD
Tadalafil—Abdominal discomfort—Methotrexate—colon cancer	0.0017	0.00222	CcSEcCtD
Tadalafil—Gastrointestinal pain—Vincristine—colon cancer	0.0017	0.00221	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00167	0.00218	CcSEcCtD
Tadalafil—Mental disorder—Capecitabine—colon cancer	0.00167	0.00218	CcSEcCtD
Tadalafil—Pain—Fluorouracil—colon cancer	0.00166	0.00216	CcSEcCtD
Tadalafil—Gastrointestinal pain—Irinotecan—colon cancer	0.00166	0.00216	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Methotrexate—colon cancer	0.00165	0.00215	CcSEcCtD
Tadalafil—Abdominal pain—Vincristine—colon cancer	0.00164	0.00214	CcSEcCtD
Tadalafil—Back pain—Capecitabine—colon cancer	0.00161	0.00209	CcSEcCtD
Tadalafil—Abdominal pain—Irinotecan—colon cancer	0.0016	0.00209	CcSEcCtD
Tadalafil—Muscle spasms—Capecitabine—colon cancer	0.0016	0.00208	CcSEcCtD
Tadalafil—Infestation—Methotrexate—colon cancer	0.00158	0.00206	CcSEcCtD
Tadalafil—Infestation NOS—Methotrexate—colon cancer	0.00158	0.00206	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00157	0.00204	CcSEcCtD
Tadalafil—Vision blurred—Capecitabine—colon cancer	0.00157	0.00204	CcSEcCtD
Tadalafil—Renal failure—Methotrexate—colon cancer	0.00156	0.00203	CcSEcCtD
Tadalafil—Urticaria—Fluorouracil—colon cancer	0.00154	0.00201	CcSEcCtD
Tadalafil—Conjunctivitis—Methotrexate—colon cancer	0.00154	0.002	CcSEcCtD
Tadalafil—Hypersensitivity—Vincristine—colon cancer	0.00153	0.002	CcSEcCtD
Tadalafil—Sweating—Methotrexate—colon cancer	0.00152	0.00198	CcSEcCtD
Tadalafil—Haematuria—Methotrexate—colon cancer	0.00151	0.00196	CcSEcCtD
Tadalafil—Epistaxis—Methotrexate—colon cancer	0.00149	0.00194	CcSEcCtD
Tadalafil—Vertigo—Capecitabine—colon cancer	0.00149	0.00194	CcSEcCtD
Tadalafil—Hypersensitivity—Irinotecan—colon cancer	0.00149	0.00194	CcSEcCtD
Tadalafil—Asthenia—Vincristine—colon cancer	0.00149	0.00194	CcSEcCtD
Tadalafil—Syncope—Capecitabine—colon cancer	0.00149	0.00194	CcSEcCtD
Tadalafil—Palpitations—Capecitabine—colon cancer	0.00147	0.00191	CcSEcCtD
Tadalafil—Loss of consciousness—Capecitabine—colon cancer	0.00146	0.0019	CcSEcCtD
Tadalafil—Asthenia—Irinotecan—colon cancer	0.00145	0.00189	CcSEcCtD
Tadalafil—Cough—Capecitabine—colon cancer	0.00145	0.00189	CcSEcCtD
Tadalafil—Hypertension—Capecitabine—colon cancer	0.00143	0.00187	CcSEcCtD
Tadalafil—Hypersensitivity—Fluorouracil—colon cancer	0.00143	0.00186	CcSEcCtD
Tadalafil—Haemoglobin—Methotrexate—colon cancer	0.00143	0.00186	CcSEcCtD
Tadalafil—Diarrhoea—Vincristine—colon cancer	0.00142	0.00185	CcSEcCtD
Tadalafil—Haemorrhage—Methotrexate—colon cancer	0.00142	0.00185	CcSEcCtD
Tadalafil—Arthralgia—Capecitabine—colon cancer	0.00141	0.00184	CcSEcCtD
Tadalafil—Chest pain—Capecitabine—colon cancer	0.00141	0.00184	CcSEcCtD
Tadalafil—Myalgia—Capecitabine—colon cancer	0.00141	0.00184	CcSEcCtD
Tadalafil—Pharyngitis—Methotrexate—colon cancer	0.00141	0.00184	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.0014	0.00183	CcSEcCtD
Tadalafil—Urinary tract disorder—Methotrexate—colon cancer	0.0014	0.00183	CcSEcCtD
Tadalafil—Discomfort—Capecitabine—colon cancer	0.0014	0.00182	CcSEcCtD
Tadalafil—Urethral disorder—Methotrexate—colon cancer	0.00139	0.00181	CcSEcCtD
Tadalafil—Diarrhoea—Irinotecan—colon cancer	0.00139	0.0018	CcSEcCtD
Tadalafil—Dry mouth—Capecitabine—colon cancer	0.00138	0.0018	CcSEcCtD
Tadalafil—Dizziness—Vincristine—colon cancer	0.00138	0.00179	CcSEcCtD
Tadalafil—Pruritus—Fluorouracil—colon cancer	0.00137	0.00179	CcSEcCtD
Tadalafil—Oedema—Capecitabine—colon cancer	0.00136	0.00177	CcSEcCtD
Tadalafil—Infection—Capecitabine—colon cancer	0.00135	0.00175	CcSEcCtD
Tadalafil—Erythema multiforme—Methotrexate—colon cancer	0.00134	0.00175	CcSEcCtD
Tadalafil—Dizziness—Irinotecan—colon cancer	0.00134	0.00174	CcSEcCtD
Tadalafil—Shock—Capecitabine—colon cancer	0.00133	0.00174	CcSEcCtD
Tadalafil—Nervous system disorder—Capecitabine—colon cancer	0.00133	0.00173	CcSEcCtD
Tadalafil—Eye disorder—Methotrexate—colon cancer	0.00133	0.00173	CcSEcCtD
Tadalafil—Diarrhoea—Fluorouracil—colon cancer	0.00133	0.00173	CcSEcCtD
Tadalafil—Tinnitus—Methotrexate—colon cancer	0.00132	0.00172	CcSEcCtD
Tadalafil—Tachycardia—Capecitabine—colon cancer	0.00132	0.00172	CcSEcCtD
Tadalafil—Vomiting—Vincristine—colon cancer	0.00132	0.00172	CcSEcCtD
Tadalafil—Cardiac disorder—Methotrexate—colon cancer	0.00132	0.00172	CcSEcCtD
Tadalafil—Skin disorder—Capecitabine—colon cancer	0.00132	0.00171	CcSEcCtD
Tadalafil—Rash—Vincristine—colon cancer	0.00131	0.00171	CcSEcCtD
Tadalafil—Hyperhidrosis—Capecitabine—colon cancer	0.00131	0.00171	CcSEcCtD
Tadalafil—Dermatitis—Vincristine—colon cancer	0.00131	0.00171	CcSEcCtD
Tadalafil—Headache—Vincristine—colon cancer	0.0013	0.0017	CcSEcCtD
Tadalafil—Angiopathy—Methotrexate—colon cancer	0.00129	0.00168	CcSEcCtD
Tadalafil—Vomiting—Irinotecan—colon cancer	0.00129	0.00168	CcSEcCtD
Tadalafil—Immune system disorder—Methotrexate—colon cancer	0.00128	0.00167	CcSEcCtD
Tadalafil—Dizziness—Fluorouracil—colon cancer	0.00128	0.00167	CcSEcCtD
Tadalafil—Mediastinal disorder—Methotrexate—colon cancer	0.00128	0.00167	CcSEcCtD
Tadalafil—Rash—Irinotecan—colon cancer	0.00128	0.00166	CcSEcCtD
Tadalafil—Dermatitis—Irinotecan—colon cancer	0.00128	0.00166	CcSEcCtD
Tadalafil—Headache—Irinotecan—colon cancer	0.00127	0.00165	CcSEcCtD
Tadalafil—Hypotension—Capecitabine—colon cancer	0.00127	0.00165	CcSEcCtD
Tadalafil—Mental disorder—Methotrexate—colon cancer	0.00124	0.00162	CcSEcCtD
Tadalafil—Nausea—Vincristine—colon cancer	0.00124	0.00161	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00123	0.00161	CcSEcCtD
Tadalafil—Vomiting—Fluorouracil—colon cancer	0.00123	0.00161	CcSEcCtD
Tadalafil—Insomnia—Capecitabine—colon cancer	0.00123	0.0016	CcSEcCtD
Tadalafil—Rash—Fluorouracil—colon cancer	0.00122	0.00159	CcSEcCtD
Tadalafil—Dermatitis—Fluorouracil—colon cancer	0.00122	0.00159	CcSEcCtD
Tadalafil—Paraesthesia—Capecitabine—colon cancer	0.00122	0.00159	CcSEcCtD
Tadalafil—Headache—Fluorouracil—colon cancer	0.00122	0.00158	CcSEcCtD
Tadalafil—Dyspnoea—Capecitabine—colon cancer	0.00121	0.00157	CcSEcCtD
Tadalafil—Nausea—Irinotecan—colon cancer	0.0012	0.00157	CcSEcCtD
Tadalafil—Back pain—Methotrexate—colon cancer	0.0012	0.00156	CcSEcCtD
Tadalafil—Dyspepsia—Capecitabine—colon cancer	0.00119	0.00155	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Capecitabine—colon cancer	0.00117	0.00152	CcSEcCtD
Tadalafil—Fatigue—Capecitabine—colon cancer	0.00117	0.00152	CcSEcCtD
Tadalafil—Vision blurred—Methotrexate—colon cancer	0.00117	0.00152	CcSEcCtD
Tadalafil—Pain—Capecitabine—colon cancer	0.00116	0.00151	CcSEcCtD
Tadalafil—Constipation—Capecitabine—colon cancer	0.00116	0.00151	CcSEcCtD
Tadalafil—Nausea—Fluorouracil—colon cancer	0.00115	0.0015	CcSEcCtD
Tadalafil—Vertigo—Methotrexate—colon cancer	0.00111	0.00145	CcSEcCtD
Tadalafil—Gastrointestinal pain—Capecitabine—colon cancer	0.00111	0.00144	CcSEcCtD
Tadalafil—Cough—Methotrexate—colon cancer	0.00108	0.00141	CcSEcCtD
Tadalafil—Urticaria—Capecitabine—colon cancer	0.00108	0.0014	CcSEcCtD
Tadalafil—Abdominal pain—Capecitabine—colon cancer	0.00107	0.0014	CcSEcCtD
Tadalafil—Convulsion—Methotrexate—colon cancer	0.00107	0.0014	CcSEcCtD
Tadalafil—Myalgia—Methotrexate—colon cancer	0.00105	0.00137	CcSEcCtD
Tadalafil—Chest pain—Methotrexate—colon cancer	0.00105	0.00137	CcSEcCtD
Tadalafil—Arthralgia—Methotrexate—colon cancer	0.00105	0.00137	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00105	0.00136	CcSEcCtD
Tadalafil—Discomfort—Methotrexate—colon cancer	0.00104	0.00135	CcSEcCtD
Tadalafil—Infection—Methotrexate—colon cancer	0.001	0.00131	CcSEcCtD
Tadalafil—Hypersensitivity—Capecitabine—colon cancer	0.000999	0.0013	CcSEcCtD
Tadalafil—Nervous system disorder—Methotrexate—colon cancer	0.000989	0.00129	CcSEcCtD
Tadalafil—Skin disorder—Methotrexate—colon cancer	0.00098	0.00128	CcSEcCtD
Tadalafil—Hyperhidrosis—Methotrexate—colon cancer	0.000975	0.00127	CcSEcCtD
Tadalafil—Asthenia—Capecitabine—colon cancer	0.000972	0.00127	CcSEcCtD
Tadalafil—Pruritus—Capecitabine—colon cancer	0.000959	0.00125	CcSEcCtD
Tadalafil—Hypotension—Methotrexate—colon cancer	0.000943	0.00123	CcSEcCtD
Tadalafil—Diarrhoea—Capecitabine—colon cancer	0.000927	0.00121	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000919	0.0012	CcSEcCtD
Tadalafil—Insomnia—Methotrexate—colon cancer	0.000913	0.00119	CcSEcCtD
Tadalafil—Paraesthesia—Methotrexate—colon cancer	0.000906	0.00118	CcSEcCtD
Tadalafil—Dyspnoea—Methotrexate—colon cancer	0.0009	0.00117	CcSEcCtD
Tadalafil—Somnolence—Methotrexate—colon cancer	0.000897	0.00117	CcSEcCtD
Tadalafil—Dizziness—Capecitabine—colon cancer	0.000896	0.00117	CcSEcCtD
Tadalafil—Dyspepsia—Methotrexate—colon cancer	0.000888	0.00116	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Methotrexate—colon cancer	0.000871	0.00113	CcSEcCtD
Tadalafil—Fatigue—Methotrexate—colon cancer	0.00087	0.00113	CcSEcCtD
Tadalafil—Pain—Methotrexate—colon cancer	0.000863	0.00112	CcSEcCtD
Tadalafil—Vomiting—Capecitabine—colon cancer	0.000862	0.00112	CcSEcCtD
Tadalafil—Rash—Capecitabine—colon cancer	0.000855	0.00111	CcSEcCtD
Tadalafil—Dermatitis—Capecitabine—colon cancer	0.000854	0.00111	CcSEcCtD
Tadalafil—Headache—Capecitabine—colon cancer	0.000849	0.00111	CcSEcCtD
Tadalafil—Gastrointestinal pain—Methotrexate—colon cancer	0.000825	0.00107	CcSEcCtD
Tadalafil—Nausea—Capecitabine—colon cancer	0.000805	0.00105	CcSEcCtD
Tadalafil—Urticaria—Methotrexate—colon cancer	0.000802	0.00104	CcSEcCtD
Tadalafil—Abdominal pain—Methotrexate—colon cancer	0.000798	0.00104	CcSEcCtD
Tadalafil—Hypersensitivity—Methotrexate—colon cancer	0.000743	0.000968	CcSEcCtD
Tadalafil—Asthenia—Methotrexate—colon cancer	0.000724	0.000943	CcSEcCtD
Tadalafil—Pruritus—Methotrexate—colon cancer	0.000714	0.00093	CcSEcCtD
Tadalafil—Diarrhoea—Methotrexate—colon cancer	0.00069	0.000899	CcSEcCtD
Tadalafil—Dizziness—Methotrexate—colon cancer	0.000667	0.000869	CcSEcCtD
Tadalafil—Vomiting—Methotrexate—colon cancer	0.000642	0.000836	CcSEcCtD
Tadalafil—Rash—Methotrexate—colon cancer	0.000636	0.000829	CcSEcCtD
Tadalafil—Dermatitis—Methotrexate—colon cancer	0.000636	0.000828	CcSEcCtD
Tadalafil—Headache—Methotrexate—colon cancer	0.000632	0.000823	CcSEcCtD
Tadalafil—Nausea—Methotrexate—colon cancer	0.000599	0.000781	CcSEcCtD
